Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Hayman

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Leukemia|May 24, 2016
Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agentsN Majithia, S V Rajkumar, M Q Lacy, et al.
Bone Marrow Transplantation|April 11, 2017
Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survivalN Tandon, E Muchtar, S Sidana, et al.
Leukemia|October 22, 2015
Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myelomaG P Kaufman, M A Gertz, A Dispenzieri, et al.
Kidney International|April 4, 2008
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chainsN Leung, M A Gertz, S R Zeldenrust, et al.
Bone Marrow Transplantation|November 5, 2013
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapyS K Kumar, J Mikhael, B Laplant, et al.
Blood Cancer Journal|March 21, 2015
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myelomaW I Gonsalves, N Leung, S V Rajkumar, et al.
Heart (British Cardiac Society)|January 10, 2014
High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosisA Dispenzieri, M A Gertz, S K Kumar, et al.
Blood Cancer Journal|May 2, 2015
Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for deathR Warsame, S K Kumar, M A Gertz, et al.
Bone Marrow Transplantation|April 23, 2013
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral centerA Dispenzieri, K Seenithamby, M Q Lacy, et al.
Leukemia|May 24, 2016
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survivalE Muchtar, A Dispenzieri, S K Kumar, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Leukemia|May 24, 2016
Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agentsN Majithia, S V Rajkumar, M Q Lacy, et al.
Bone Marrow Transplantation|April 11, 2017
Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survivalN Tandon, E Muchtar, S Sidana, et al.
Leukemia|October 22, 2015
Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myelomaG P Kaufman, M A Gertz, A Dispenzieri, et al.
Kidney International|April 4, 2008
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chainsN Leung, M A Gertz, S R Zeldenrust, et al.
Bone Marrow Transplantation|November 5, 2013
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapyS K Kumar, J Mikhael, B Laplant, et al.
Blood Cancer Journal|March 21, 2015
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myelomaW I Gonsalves, N Leung, S V Rajkumar, et al.
Heart (British Cardiac Society)|January 10, 2014
High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosisA Dispenzieri, M A Gertz, S K Kumar, et al.
Blood Cancer Journal|May 2, 2015
Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for deathR Warsame, S K Kumar, M A Gertz, et al.
Bone Marrow Transplantation|April 23, 2013
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral centerA Dispenzieri, K Seenithamby, M Q Lacy, et al.
Leukemia|May 24, 2016
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survivalE Muchtar, A Dispenzieri, S K Kumar, et al.
Pageof 6